Convergent Research

Overview

Builds and operates focused research organizations that identify scientific bottlenecks, match funders with teams, and provide operational support for public research infrastructure.

Part of the Boston ecosystem

Related

• AsimovBuilds an end-to-end genetic design platform combining synthetic biology and computational tools for biologics, cell therapy, and gene therapy development.
• Boston Tech Week 2026Citywide unconference coordinating community-created events over seven days, with submission support, a shared calendar, and promotion that helps event hosts reach broader audiences.
• General CatalystInvests in portfolio companies and acquired a hospital system to test a model for more proactive, accessible, affordable healthcare for American patients.
• MassChallengeBoston-based equity-free accelerator with sector-specific tracks (HealthTech, FinTech, FrontierTech). Each cohort runs 4 months with a $0 equity model funded by sponsors and government partners.
• Merck Cambridge Discovery ($MRK)Develops medicines and vaccines through research, clinical trials, and publications, focusing on diseases including cancer, infectious, cardiometabolic, respiratory, immune, neurological, and eye conditions.
• MITProvides education, research, innovation, and public service to prepare learners, advance knowledge, and address needs of the nation and world.
• MIT delta vAccelerates startup teams by providing mentors, investor networks, partner office hours, workshops, and perks for builders developing ventures that need scaling support.
• Northpond VenturesBuilds and supports science- and technology-driven businesses, including point-of-care diagnostics, for innovators developing breakthroughs with human health applications and broader societal impact.
• OpenEvidenceSearches medical knowledge with AI. Also: Biotech.
• Pillar VCInvests at inception in technical founders pursuing breakthrough companies, and provides founder resources such as playlists, startup templates, events, and guides.
• Relay Therapeutics ($RLAY)Develops small molecule medicines using computational and experimental protein-motion analysis, targeting previously hard-to-drug precision medicine targets in oncology and genetic disease.
• Safar PartnersInvests in seed to growth-stage platform technology companies from academic research, supporting founders tackling major challenges in clean technology, materials, AI, robotics, life sciences, and medical devices.